In recent years, our country high frequency promulgates the policy to encourage the domestic medical device development, the domestic medical device enterprise welcome the Golden Opportunity Period. High-value medical consumables as an important segment of the market for medical devices, after years of rapid development, a full range of products. Domestic high-value medical consumables can basically achieve full coverage of varieties, orthopedics, Vascular Intervention, ophthalmology and other high-value medical consumables and biomaterials made significant progress and breakthroughs, a number of excellent listed companies have emerged. With the acceleration of urbanization and population ageing in our country, the incidence of diseases such as cerebrovascular disease, neurological disorder, ophthalmic diseases and tumors is on the rise, high-value medical consumables such as orthopaedics, Ophthalmology and vascular intervention have broad prospects. With the rapid development of medical industry, the global high-value medical consumables market is growing rapidly. In 2019, the global market for high-value medical consumables was US $163.427 billion (Figure 1) , with a CAGR of 14.83% from 2015 to 2019.
Image 1. PNG in recent years, China's high-value medical consumables industry closely combined with industry resources, fully grasp the changes in user demand, enrich the application scenario, bring consumables demand growth year by year. In 2015, the market scale of our country's high-value medical consumables industry was 60.2 billion yuan, which increased to 129.2 billion yuan in 2019(see Figure 2) . The annual compound growth rate from 2015 to 2019 was 21.04% . In 2020, affected by covid-19, the demand for high-value medical consumables will increase rapidly, and the market size is expected to exceed 160 billion yuan. It is estimated that the 2026 market of high-value medical consumables in our country will reach 335.6 billion yuan, but the growth rate of the market will slow down year by year due to factors such as belt purchase and import substitution.
